세계 프로테오믹스 시장 규모는 2024-2030년의 예측 기간 동안 연평균 13.54% 성장할 것으로 예상됩니다. 시장은 주로 다양한 만성 질환 및 표적 질환을 치료하기 위한 맞춤형 의료에 대한 수요 증가로 인해 큰 시장 성장을 보이고 있습니다. 또한, 암, 심혈관 질환(CVD), 호흡기 질환, 만성 신장 질환(CKD)과 같은 다양한 표적 질환의 높은 유병률, 질병 진단 및 치료를 위한 의약품 설계, 바이오마커 발굴, 임상 진단에 대한 제품 사용에 대한 관심이 높아짐에 따라 프로테오믹스에 대한 시장 수요가 증가하고 있습니다. 또한, 제품 및 서비스 출시 및 승인 증가, 주요 기업 시장 진출 등의 요인으로 인해 프로테오믹스 시장에서의 요구사항이 증가하고 있습니다. 마지막으로, 전체 의료 부문의 확대와 신약 개발, 의료 산업의 주요 기업들의 투자 급증은 연구개발 활동을 증가시켜 수요에 영향을 미칠 것으로 보입니다. 따라서 시장은 2024-2030년의 예측 기간 동안 상당한 CAGR로 성장할 것으로 추정됩니다.
프로테오믹스 시장 역학
프로테오믹스 시장의 중요한 촉진요인 중 하나는 암, 심혈관 질환 등 다양한 만성 질환의 유병률 증가입니다.
예를 들어, 세계보건기구(WHO)(2022)에 따르면 암은 전 세계 주요 사망 원인으로 2020년 약 1,000만 명이 사망했으며, 2020년 전 세계 유방암 신규 발병 건수는 226만 건이었습니다. 같은 자료에 따르면 2020년 전 세계 신규 폐암 환자수는 221만 명, 대장암 193만 명, 전립선암 141만 명, 피부암 120만 명, 위암 109만 명으로 집계됐습니다. 또한 WHO(2022)에 따르면 심혈관 질환(CVD)은 전 세계 주요 사망 원인으로 매년 약 1,790만 명의 목숨을 앗아가는 것으로 추정됩니다.
프로테오믹스는 바이오마커와 치료 표적을 발견할 수 있는 독특한 도구를 제공함으로써 암 예방과 치료에 기여할 것으로 기대되고 있습니다. 따라서 만성 질환의 유병률 증가는 개인 맞춤형 의료에 대한 수요를 증가시켜 시장에서 프로테오믹스 수요 증가로 이어질 것입니다.
프로테오믹스 연구개발에 대한 투자 증가는 프로테오믹스 시장의 주요 성장 요인 중 하나이며, 2022년 미국 국립보건원(NIH)은 의학 연구에 450억 달러의 자금을 지원했습니다. 이 자금은 질병의 존재를 나타내는 바이오마커를 식별하고 질병을 유발하는 유전자와 단백질을 식별하는 등 질병이 발생하는 기본적인 과정을 이해하려는 생명과학 연구를 지원하는 것을 목표로 했습니다. 또한, 2020년에는 노보 노디스크 재단이 코펜하겐 대학으로부터 질량 분석 시설 설립을 위해 최대 150만 달러의 보조금을 지원받으며 단백질 연구에 큰 진전을 이루었습니다. 이처럼 전 세계 정부 및 주요 기업들의 이러한 투자와 자금 지원은 R&D 활동을 활성화하고, 이는 결국 프로테오믹스 시장에 영향을 미치게 될 것입니다.
또한, 의료비 상승, 맞춤형 의약품에 대한 수요 증가, 유전성 질환의 비율 증가는 예측 기간 동안 프로테오믹스에 대한 수요를 증가시킬 것입니다.
따라서 위의 요인들이 종합적으로 2024-2030년의 예측 기간 동안 전체 프로테오믹스 시장을 견인할 것으로 보입니다.
그러나 높은 기기 비용과 모호한 규제 프레임워크는 프로테오믹스 시장 성장에 걸림돌로 작용할 수 있습니다.
프로테오믹스 시장은 코로나19 팬데믹 기간 동안 긍정적인 영향을 받았습니다. 팬데믹 초기에는 엄격한 봉쇄 조치로 인해 생산과 공급이 중단되면서 프로테오믹스 기기와 서비스에 대한 수요가 감소했습니다. 그러나 프로테오믹스 기법과 장비는 백신 개발을 위한 바이오마커를 조사하기 위해 코로나19 백신 개발에 사용되었습니다. 또한, 프로테오믹스 접근법은 단백질과 그 번역 후 변형의 정량화 및 차등적 발현을 제공할 수 있기 때문에 코로나19 연구에 적합했습니다. 이처럼 코로나19 백신에 대한 연구가 증가함에 따라 프로테오믹스 기기 및 서비스에 대한 수요는 크게 증가할 것입니다. 마찬가지로, 록다운 규제 완화, 자원 및 공급망 회복, 대중에 대한 백신 접종, 연구 및 개발 활동에서 프로테오믹스 수요 증가로 인해 프로테오믹스 수요는 2022-2028년의 예측 기간 동안 증가할 것으로 예상됩니다.
이 보고서는 세계 프로테오믹스 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.
Proteomics Market By Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, And Other], Reagents & Consumables, And Software & Services), By Application (Clinical Diagnostics, Drug Discovery, And Others), By End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of various chronic diseases and the rising demand for personalized medicine across the globe
The global proteomics market is estimated to grow at a CAGR of 13.54% during the forecast period from 2024 to 2030. The proteomics market is observing significant market growth primarily due to the growing demand for personalized medicines to treat various chronic or targeted diseases. Further, the increasing need for advanced diagnostics in targeted disease treatment, the high prevalence of various target diseases such as cancer, cardiovascular diseases (CVDs), respiratory diseases, and chronic kidney diseases (CKD) across the world, and the increasing focus on product usage in drug designing, biomarker discoveries, and clinical diagnostics for the diagnosis and treatment of diseases will create the need for proteomics in the market. Additionally, the increasing product and service launches and approvals, the presence of key players in the market, and other factors will create a requisite for proteomics in the market. Lastly, the increasing overall healthcare sector, drug discovery, and surging investments by key players in the healthcare industry will in turn increase the research & developmental activities, ultimately affecting the demand certainly. Therefore, the market of proteomics is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.
Proteomics Market Dynamics:
One of the key aspects driving the proteomics market is the rising prevalence of various chronic diseases such as cancer, cardiovascular diseases, and others.
For instance, according to the World Health Organization (WHO) 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The new cases of breast cancer in 2020 were 2.26 million cases, across the globe. The same source stated that lung cancer accounted for 2.21 million new cases, colon and rectum cancer for 1.93 million new cases, prostate cancer with 1.41 million new cases, skin cancer accounted for 1.20 million new cases, and stomach cancer new cases were 1.09 million in 2020, globally. Further, according to WHO 2022, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year.
Thus, owing to the increasing prevalence of various life-threatening diseases and increasing demand for personalized therapies resulting in a positive impact on the market of proteomics as proteomics holds great promise in contributing to the prevention and cure of cancer because it provides unique tools for the discovery of biomarkers and therapeutic targets. Therefore, the increasing prevalence of chronic diseases will increase the demand for personalized medicine, eventually leading to an increased demand for proteomics in the market.
The increasing investments in proteomics R&D are one of the prominent growth drivers of the proteomics market. In 2022, the National Institutes of Health (NIH) of the United States provided USD 45 billion for medical research. This funding was intended to support life sciences research that sought to understand the fundamental processes by which diseases develop, such as the identification of biomarkers that indicate the presence of disease or the identification of the gene/protein responsible for the disease. Also, in 2020, Novo Nordisk Foundation was awarded the University of Copenhagen grant of up to USD 1.5 million to establish a mass spectrometry facility, which is a significant step forward in protein research. Thus, such investments and funding by the government and key players across the globe will increase the research & developmental activities, which in turn will affect the market of proteomics.
Further, rising healthcare costs, growing demand for tailored medication, and rising rates of genetic illnesses will increase the demand for proteomics during the forecast period.
Therefore, the factors stated above collectively will drive the overall proteomics market during the forecast period from 2024-2030.
However, the high cost of instruments, the presence of ambiguous regulatory framework, and others may prove to be challenging factors for the proteomics market growth.
The proteomics market was positively impacted during the period of the COVID-19 pandemic. During the initial stage of the pandemic, the demand for proteomics instruments and services suffered a downfall owing to the imposition of strict lockdown rules, and disruption in manufacturing, and supply. However, the proteomics techniques and instruments were used in the development of the Covid-19 vaccine to research the biomarker for vaccine development. Moreover, the proteomic approach was well suited for studying COVID-19 since it can provide quantitation and differential expression of proteins and their post-translational modifications. Thus, as the research for the COVID-19 vaccine increases, the demand for proteomics instruments and services upsurges considerably. Likewise, with the ease of lockdown restrictions, the upturn of resources and supply chain, the administration of a vaccine to the public, and with the increasing demand of proteomics for research & development activities, the demand for proteomics increases and is anticipated to do the same during the forecast period from 2022 - 2028.
Proteomics Market Segment Analysis:
Proteomics Market by Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, and Other], Reagents & Consumables, and Software & Services), Application (Clinical Diagnostics, Drug Discovery, and Others), End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the product type segment of the proteomics market, the electrophoresis segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the rising availability of technologically advanced instrumentation in the market, rising instrument launches and approvals in the market, and rising demand for electrophoresis in research & developmental activities.
Electrophoresis is one of the most conventional techniques used in biotechnology, which separates the particles based on the charge and size they possess. This technology can be used for the diagnosis of various diseases, DNA sequencing, analysis of antibodies and steroids, and other medical research activities. Moreover, the electrophoresis technique is used to identify many proteins that are significant for improved characterization of tumor progression and molecular specificity of both lung cancer subtypes. As a result of electrophoresis, it is possible to distinguish proteins from tumor cells, which aids in tumor diagnosis and may contribute to the segment's growth.
Further, various other strategic steps taken by the key players in the market will help in increasing the demand for electrophoresis. For instance, in September 2020, miniPCR bio launched GELATO, a gel electrophoresis system, a type of electrophoresis with an integrated blue light with transillumination technology, allowing simultaneous nucleic acid separation.
Therefore, owing to the above-mentioned factors, the demand for electrophoresis rises, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global proteomics market during the forecast period.
North America is expected to dominate the overall Proteomics Market:
Among all the regions, North America is expected to dominate global proteomics in the year 2023 and is expected to do the same during the forecast period from 2024-2030.
This can be ascribed to the increasing need for advanced diagnostics in targeted disease treatment, the rising prevalence of target diseases across the world, and the presence of key market players in the region are the key reasons which act as a supportive factor for the North America proteomics market growth.
For instance, according to the Cancer Facts & Figures 2022, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. The increasing incidence of cancer in the region will increase the demand for proteomics as the instrumentation is employed in the detection of tumors in a patient.
Additionally, the increasing number of novel and next-generation therapeutics approved in the region will increase the demand for proteomics. Also, the rising investments in the field of personalized medicine, the presence of globally leading market players, increasing research in the fields of omics, and the rising investments in the area of structure-based drug design will in turn increase the demand for proteomics in the North America.
Further, increasing product launches of various technologically advanced proteomics instrumentations and strategic steps such as collaboration, acquisition, and partnership by key players in the region will ultimately increase its demand. For instance, in March 2022, Thermo Fisher Scientific, the world leader in serving science, and Protein Metrics, a developer of world-class software tools for protein characterization, entered into a non-exclusive co-marketing agreement to provide advanced mass spectrometry data processing and analysis capabilities to drive innovation across the full spectrum of biopharmaceutical and proteomics applications, from research and development to quality control.
Therefore, the interplay of the aforementioned factors would provide a conducive growth environment for the North American region in the proteomics market.
Proteomics Market Key Players:
Some of the key market players operating in the proteomics market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Danaher., General Electric Company, Bruker, Merck KGaA, Promega Corporation., Waters Corporation., Illumina, Inc., Creative Proteomics., VProteomics, HORIBA, Ltd., Applied Biomics., Fios Genomics., and others.
Recent Developmental Activities in the Proteomics Market:
In January 2022, PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, raised Euro 13.5m in a Series B financing round provided by Bruker Corporation.
In August 2022, Bruker Corporation, announced the launch of the new nanoEluteR 2 nano-LC, of MetaboScapeR and TASQR 2023 software supporting fluxomics, and of the latest advances in PaSER(TM)'s intelligent acquisition to enhance research in protein-protein interactions (PPIs) and metaproteomics applications.
In February 2020, Applied Biomics, Inc., a leading Proteomics service provider, added an HCP profiling analysis using their well-established high-resolution, large format 2-Dimensional Differential In-Gel Electrophoresis (2D DIGE) platform.
Key Takeaways from the Proteomics Market Report Study
Market size analysis for current proteomics market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Proteomics market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global proteomics market.
Various opportunities available for the other competitor in the proteomics market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current proteomics market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for proteomics market growth in the coming future?
Target Audience who can be benefited from this Proteomics Market Report Study
Proteomics products providers
Research organizations and consulting companies
Proteomics-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in proteomics
Various end users who want to know more about the proteomics market and the latest technological developments in the proteomics market.
Frequently Asked Questions for the Proteomics Market:
The study of protein structure and function is known as proteomics. Proteomics is concerned with topics such as which proteins are expressed, when and where they are expressed, what their structures are in both active and inactive states, what roles they play in cell life, and how they interact with other proteins and molecules.
The global proteomics market is estimated to grow at a CAGR of 13.54% during the forecast period from 2024 to 2030.
The proteomics market is witnessing positive market growth owing to the factors such as growing demand for personalized medicines, increasing need for advanced diagnostics in targeted disease treatment, high prevalence of target diseases across the world, increasing focus on product usage in drug designing, biomarker discoveries, and clinical diagnostics for the diagnosis and treatment of diseases, increasing product launches and approvals, presence of key players in the market, and others will create an exigency for the proteomics market.
Some of the key market players operating in the proteomics market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Danaher., General Electric Company, Bruker, Merck KGaA, Promega Corporation., Waters Corporation., Illumina, Inc., Creative Proteomics., VProteomics, HORIBA, Ltd., Applied Biomics., Fios Genomics., and others.
Among all the regions, North America is estimated to amass a significant revenue share in the global Proteomics market. This can be ascribed to the increasing need for advanced diagnostics in targeted disease treatment, the rising prevalence of target diseases across the world, and the presence of key market players in the region are the reasons which act as a supportive factors for the North America proteomics market growth.